Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VESPER-JW: Berobenatide in Japanese Adults with Obesity
NCT07794761Phase 3Recruiting
- Sponsor
- Pfizer
- Start
- Oct 2026
- Primary completion
- Mar 2029
- Countries
- 1
01
Overview
A Phase 3 trial of berobenatide in obesity, sponsored by Pfizer. Started Oct 2026; status: recruiting.
02
Drugs
berobenatide
03
Conditions
obesity
Beyond the preview
Go deeper on NCT07794761.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07794761.